Page last updated: 2024-10-27

fluconazole and Pulmonary Fibrosis

fluconazole has been researched along with Pulmonary Fibrosis in 4 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research Excerpts

ExcerptRelevanceReference
"Prior use of fluconazole, severe respiratory failure and hospitalization time are associated with IPA in patients with chronic pneumopathies with respiratory isolation of Aspergillus spp."1.38[Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp]. ( Casal, M; Castón, JJ; Linares, MJ; Rivero, A; Torre-Cisneros, J, 2012)
"We present here three AIDS patients with disseminated cryptococcal infection and lung involvement."1.28[Pulmonary cryptococcosis in AIDS]. ( Ariza, J; Carratalà, J; Martos, A; Mascaró, J; Podzamczer, D; Santín, M, 1992)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morais, EA1
Martins, EM1
Boelone, JN1
Gomes, DA1
Goes, AM1
Castón, JJ1
Linares, MJ1
Rivero, A1
Casal, M1
Torre-Cisneros, J1
FRIDKIN, VIa1
ROZENSHTRAUKH, LS1
Martos, A1
Mascaró, J1
Santín, M1
Ariza, J1
Carratalà, J1
Podzamczer, D1

Other Studies

4 other studies available for fluconazole and Pulmonary Fibrosis

ArticleYear
Immunization with recombinant Pb27 protein reduces the levels of pulmonary fibrosis caused by the inflammatory response against Paracoccidioides brasiliensis.
    Mycopathologia, 2015, Volume: 179, Issue:1-2

    Topics: Animals; Antifungal Agents; Antigens, Fungal; Caspase 3; Collagen; Fluconazole; Fungal Proteins; Fun

2015
[Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp].
    Medicina clinica, 2012, Dec-15, Volume: 139, Issue:15

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Asthma; Bacterial Infections; Carrier State

2012
[Bronchial tree in lobar and zonal atelectasis and pulmonary cirrhosis].
    Voprosy onkologii, 1959, Volume: 5

    Topics: Fluconazole; Humans; Lung; Pulmonary Atelectasis; Pulmonary Fibrosis; Trees

1959
[Pulmonary cryptococcosis in AIDS].
    Enfermedades infecciosas y microbiologia clinica, 1992, Volume: 10, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Cr

1992